(Public, NASDAQ:XRAY)   Watch this stock  
Find more results for xray
+0.72 (1.25%)
Sep 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 57.65 - 58.60
52 week 52.53 - 65.68
Open 57.75
Vol / Avg. 970,334.00/2.03M
Mkt cap 13.43B
P/E     -
Div/yield 0.09/0.60
EPS -3.47
Shares 229.50M
Beta 1.28
Inst. own 97%
Nov 2, 2017
Q3 2017 Dentsply Sirona Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 6, 2017
Dentsply Sirona Inc at Robert W Baird Gobal Healthcare Conference
Aug 9, 2017
Q2 2017 Dentsply Sirona Inc Earnings Release
Aug 9, 2017
Q2 2017 Dentsply Sirona Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -105.80% 11.52%
Operating margin -105.57% 12.14%
EBITD margin - 24.35%
Return on average assets -37.54% 5.41%
Return on average equity -54.64% 8.23%
Employees 15,700 -
CDP Score - C


221 W Philadelphia St
YORK, PA 17401-2991
United States - Map
+1-717-8457511 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.

Officers and directors

Bret W. Wise Executive Chairman of the Board
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jeffrey T. Slovin Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Ulrich Michel Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Christopher Thomas Clark President and Chief Operating Officer - Technologies
Age: 55
Bio & Compensation  - Reuters
Maureen J. MacInnis Chief Human Resource Officer, Senior Vice President
Age: 56
Bio & Compensation  - Reuters
Rainer Berthan Executive Vice President, Manufacturing and Supply Chain
Age: 53
Bio & Compensation  - Reuters
Jonathan I. Friedman Senior Vice President, General Counsel, Secretary
Age: 46
Bio & Compensation  - Reuters
Thomas Jetter Ph.D. Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
David K. Beecken M.D. Director
Age: 70
Bio & Compensation  - Reuters
Arthur D. Kowaloff Director
Age: 70
Bio & Compensation  - Reuters